Orange Book product · Generic (ANDA)
AMITRIPTYLINE HYDROCHLORIDE
AMITRIPTYLINE HYDROCHLORIDE
At a glance
Oct 06, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 06, 2017
8 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
AMITRIPTYLINE HYDROCHLORIDE
Strength
10MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 210086
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMITRIPTYLINE HYDROCHLORIDE
- —ELAVILBrand (NDA)
NDA 012704 · ASTRAZENECA
- 2022AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216243 · BRECKENRIDGE
- 2021AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212654 · AIPING PHARM INC
- 2021AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213999 · MANKIND PHARMA
- 2014AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 202446 · ACCORD HLTHCARE
- 1987AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 089423 · MUTUAL PHARM
- 1984AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088672 · AM THERAP
- 1984AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088673 · AM THERAP
- 1984AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088674 · AM THERAP
- 1984AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088675 · AM THERAP
- 1984AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088697 · PAR PHARM
- 1984AMITRIPTYLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088421 · COPLEY PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
